Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

1.3K
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.3K
Atypical Pneumonia01:14

Atypical Pneumonia

49
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
49
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

1.2K
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.2K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

4.2K
The pathophysiology of pneumonia involves the following steps:
4.2K
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

4.0K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
4.0K
Pneumonia IV: Management01:28

Pneumonia IV: Management

1.1K
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anesthetic care influences long-term outcomes: What is the evidence?

Best practice & research. Clinical anaesthesiology·2021
Same author

A highly transmissible tuberculosis outbreak: the importance of bars.

Epidemiology and infection·2017
Same author

Predictive factors, microbiology and outcome of patients with parapneumonic effusion.

The European respiratory journal·2011
Same author

Prospective, randomised study to compare empirical treatment versus targeted treatment on the basis of the urine antigen results in hospitalised patients with community-acquired pneumonia.

Thorax·2009
Same author

Paroxysmal hemicrania-tic syndrome responsive to acetazolamide.

Cephalalgia : an international journal of headache·2005
Same author

Nonsevere community-acquired pneumonia: correlation between cause and severity or comorbidity.

Archives of internal medicine·2001
Same journal

Vaccination status of patients undergoing HIV treatment in a hospital in Madrid.

Revista clinica espanola·2026
Same journal

Sulfonylureas and fracture risk in patients with type 2 diabetes mellitus: a systematic review and meta-analysis.

Revista clinica espanola·2026
Same journal

Risk factors for the development of in-hospital complications in pluripathological patients.

Revista clinica espanola·2026
Same journal

Features, treatment and 1-year prognosis of patients with heart failure and chronic kidney disease stages 4 or 5.

Revista clinica espanola·2026
Same journal

Notification of suspected adverse drug reactions by nurses to a hospital pharmacovigilance program. Retrospective descriptive study.

Revista clinica espanola·2026
Same journal

Venous thromboembolic disease associated with hormonal contraceptives. Venous Thromboembolism Group of the Spanish Society of Internal Medicine and the Catalan Society of Contraception.

Revista clinica espanola·2026
See all related articles

Related Experiment Video

Updated: Apr 6, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.8K

Community-acquired pneumonia.

M Falguera1, M F Ramírez1

  • 1Servicio de Medicina Interna, Hospital Universitari Arnau de Vilanova, Lleida, España.

Revista Clinica Espanola
|July 19, 2015
PubMed
Summary
This summary is machine-generated.

This review covers community-acquired pneumonia (CAP) and healthcare-associated pneumonia (HCAP), offering updated clinical insights. It addresses controversies and common approaches for managing these respiratory infections in frail patients.

Keywords:
BiomarcadoresBiomarkersClinical manifestationsCommunity-acquired pneumoniaDiagnosisDiagnósticoEpidemiologyEpidemiologíaFactores de riesgoManifestaciones clínicasNeumonía adquirida en la comunidadPrognosisPronósticoRisk factors

More Related Videos

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
15:43

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Published on: March 17, 2014

24.2K
Tools for the Real-Time Assessment of a Pseudomonas aeruginosa Infection Model
07:39

Tools for the Real-Time Assessment of a Pseudomonas aeruginosa Infection Model

Published on: April 6, 2021

4.3K

Related Experiment Videos

Last Updated: Apr 6, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.8K
Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
15:43

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Published on: March 17, 2014

24.2K
Tools for the Real-Time Assessment of a Pseudomonas aeruginosa Infection Model
07:39

Tools for the Real-Time Assessment of a Pseudomonas aeruginosa Infection Model

Published on: April 6, 2021

4.3K

Area of Science:

  • Pulmonology
  • Infectious Diseases
  • Internal Medicine

Background:

  • Community-acquired pneumonia (CAP) remains a significant clinical challenge.
  • Healthcare-associated pneumonia (HCAP) represents a variant affecting vulnerable populations.
  • Distinguishing and managing these conditions requires updated knowledge.

Purpose of the Study:

  • To provide a comprehensive review of CAP for clinical practice.
  • To highlight controversial aspects and recent advancements in pneumonia management.
  • To discuss the relationship between CAP and HCAP.

Main Methods:

  • Literature review of essential aspects of CAP.
  • Analysis of controversial issues in pneumonia diagnosis and treatment.
  • Inclusion of the latest available information on pneumonia variants.

Main Results:

  • Essential clinical aspects of CAP are reviewed.
  • Controversial issues and new information are presented.
  • HCAP is discussed as a variant of CAP affecting frail patients.

Conclusions:

  • A broad approach to CAP, including HCAP, is recommended.
  • Understanding risk factors and patient frailty is crucial for managing HCAP.
  • Updated clinical knowledge is vital for effective pneumonia care.